Title Category Credit Event datesort descending Cost
Direct-to-Consumer Genetic Testing: Providing Personalized Medicine
  • Disease management
  • Wellness
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 CCMC - General - Case Managers
  • 1.00 ASWB - Social Workers
 $0.00 This activity will provide an overview on direct-to-consumer (DTC) genetic testing, the role of HCPs in helping consumers make educated decisions about using these services and the future of DTC genetic testing.
Tips and Techniques for Accommodating Hearing Loss
  • Disease management
  • Older adults
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 CCMC - General - Case Managers
  • 1.00 ASWB - Social Workers
 $0.00 This activity will discuss challenges surrounding hearing health care for individuals with hearing loss, including older adults, and highlight effective techniques, tools and resources for these individuals.
Genetic Testing and Treatment: Part 1, Neuromuscular Diseases
  • Disease management
  • Wellness
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 CCMC - General - Case Managers
  • 1.00 ASWB - Social Workers
 $0.00 The goal of this activity is to assist health care professionals (HCPs) in understanding how the vast and growing field of genetic testing can impact the plan of care and treatment for individuals with neuromuscular diseases. The importance of gathering an individual’s comprehensive history and exam, along with use of current available evidence to inform decisions on next steps in evaluation and testing, will be reviewed. Additionally, faculty will discuss the important role of a genetic counselor during the decision-making process.
From the Frontlines of the War on COVID-19
  • Covid-19
  • Disease management
  • Infectious diseases
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 ASWB - Social Workers
 $0.00 This activity focuses on the challenges faced by health care professionals (HCPs) in New York during the height of the COVID-19 pandemic. It details ethical dilemmas caused by workforce and resource allocation issues, as well as palliative care practices used to support patients and their loved ones. 
COVID-19 Vaccines
  • Covid-19
  • Disease management
  • Infectious diseases
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 ASWB - Social Workers
 $0.00 This activity focuses on the current state of COVID-19 vaccine development. It discusses which vaccine types are being developed and where they are in the clinical trial process. Additionally, this activity identifies what it means for a health system to participate in a vaccine study and how health care professionals can make informed decisions about vaccines with limited available data.
COVID-19: Neutralizing Antibodies
  • Covid-19
  • Disease management
  • Infectious diseases
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 ASWB - Social Workers
 $0.00 This activity focuses on monoclonal antibodies and how they are used in therapeutics, including clinical trials for COVID-19. It discusses the risks associated with using monoclonal antibodies in infectious disease treatment and provides detailed information regarding antibody therapies currently under investigation.
As Science Moves to Genetic Testing and Treatment: Part 2, Genetic-Informed Treatments
  • Disease management
  • Pediatrics
  • Wellness
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 CCMC - General - Case Managers
  • 1.00 ASWB - Social Workers
 $0.00 This activity will discuss the importance of data and evidence regarding the use of genetics/genomics in treatment planning.
Developing an Optimal COVID-19 Test Program: Strategies and Considerations for Success
  • Covid-19
  • Disease management
  • Infectious diseases
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 ASWB - Social Workers
 $0.00 This activity will identify pathways to creating effective, practical and sustainable testing strategies for COVID-19 that can accelerate a return to normalcy and allow schools and other facilities to remain open. It will relay to participants how determining the goal of testing is the key factor to establishing an optimal testing strategy through consideration of multiple factors, including test type, sensitivity and turnaround time as well as program implementation and costs. Current testing programs will be discussed, examining how the selection of these elements can be adapted to satisfy the needs of the target community as well as the testing program’s goals. The roles that communication and partnership can play in establishing effective strategies, enhancing safety, enabling improved implementation and shaping public policy will also be examined. 
Diabetic Kidney Disease: Improving Outcomes and Reducing Costs
  • Disease management
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 ASWB - Social Workers
 $0.00 This activity will present HCPs with the information necessary to evaluate kidney health in individuals with type 2 diabetes mellitus (T2DM) and will discuss CKD risk stratification, including interpretation of albuminuria levels and estimated glomerular filtration rate (eGFR). Interventions that can reduce progression of disease, likelihood of hospitalization and costs will be identified, and recent data about effective treatment regimens and their indications for improving outcomes will be examined. Additionally, early strategies to decrease the risk for CVD and ESRD in these individuals will be defined, with a review of the pathophysiology of progression of these disorders. 
Threading the Needle: Practical Considerations in the Modern, Evidence-based Management of Type 2 Diabetes
  • Disease management
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 ASWB - Social Workers
 $0.00 This activity will assist learners in identifying optimal lifestyle and behavioral changes that can impact disease development and progression in their patients and will discuss practical strategies and forms of support that HCPs can offer to assist patients in setting healthy lifestyle goals. Learners will examine how appropriate prescribing decisions must be based on a comparative analysis of diabetes medications and will also review disease etiology and biological changes seen during disease progression. Lastly, the presenter will discuss policy and system changes that can best assist in integrating evidence into daily practice for the purpose of maximizing health in individuals with T2D. 

Pages